Drug Shortage Report for SYNTHROID
Report ID | 122563 |
Drug Identification Number | 02172135 |
Brand name | SYNTHROID |
Common or Proper name | LEVOTHYROXINE |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | LEVOTHYROXINE SODIUM |
Strength(s) | 175MCG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 90BT, 1000BT |
ATC code | H03AA |
ATC description | THYROID PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-08-14 |
Estimated end date | 2020-09-01 |
Actual end date | 2020-09-01 |
Shortage status | Resolved |
Updated date | 2020-09-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-08-20 | English | Compare |
v2 | 2020-08-20 | French | Compare |
v3 | 2020-09-01 | English | Compare |
v4 | 2020-09-01 | French | Compare |
v5 | 2020-09-02 | English | Compare |
Showing 1 to 5 of 5